Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
3.760
+0.070 (1.90%)
At close: Feb 13, 2026
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.37 billion as of February 13, 2026.
Market Cap
1.37B
Enterprise Value
798.65M
Revenue
58.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.76
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.37B, a decrease of -81.92%. That is a compound annual growth rate of -73.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.35B | -24.54% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.84B |
| Immunotech Biopharm | 1.54B |
| HighTide Therapeutics | 1.50B |
| CANbridge Pharmaceuticals | 1.50B |
| Shanghai Bio-heart Biological Technology | 1.45B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.33B |
| 3D Medicines | 1.13B |